CEFTRIAXONE SODIUM Recall D-0620-2023
Description: Ceftriaxone for Injection, USP 10 grams per Pharmacy Bulk Package, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-098-01
CEFTRIAXONE SODIUM Recall D-0620-2023 Information
Status | Ongoing |
Mandated? | Voluntary: Firm initiated |
Recall Number | D-0620-2023 |
Event ID | 92341 |
Brand | CEFTRIAXONE |
Generic Name | CEFTRIAXONE |
Manufacturer | CEFTRIAXONE |
Original Package? | 1 |
Active Substance | CEFTRIAXONE SODIUM |
Drug Route | INTRAVENOUS |
Distribution | Nationwide within the United States |
Quantity | 7,940 bottles |
Recall Reason | Lack of Assurance of Sterility |
Drug Classification | Class II |
Drug Code Info | 20230524 |
Product NDC | 70594-098 |
Recall Initiation Date | 20230515 |
Report Date | 20230524 |
Classification Date | 20230518 |
Address | 911 G I D C Makarpura Vadodara, India |
Recalling Firm | Astral SteriTech Private Ltd. |
Initial Notification | Letter |
Unique Ingredient Identifier | 023Z5BR09K |
Drug Application Number | ANDA091117 |
Structured Product Labeling (SPL ID) | d4819f4d-0e62-4647-b642-2727358f8727 |
Structured Product Labeling (SPL Set ID) | 856be1ac-03a6-47be-b4a8-e9e8e7c87da5 |
Similar To |